Evidence map›Paper›PMID 20440532›Full record

ArticleCellular and molecular life sciences : CMLS2010

Blocking of melatonin synthesis and MT(1) receptor impairs the activation of Jurkat T cells.

Patricia J Lardone, Amalia Rubio, Isabel Cerrillo, Araceli Gómez-Corvera, Antonio Carrillo-Vico, Marina Sanchez-Hidalgo, Juan M Guerrero, Patricia Fernandez-Riejos, Victor Sanchez-Margalet, Patrocinio Molinero

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Melatonin transport into mitochondria.Cellular and molecular life sciences : CMLS · 2017
    Review
  7. Review
  8. Update on melatonin receptors: IUPHAR Review 20.British journal of pharmacology · 2016
    Review
  9. Article
  10. Review
  11. Article
  12. Melatonin: buffering the immune system.International journal of molecular sciences · 2013
    Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Patricia J LardoneInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Department of Medical Biochemistry and Molecular Biology, University of Seville School of Medicine, Sanchez Pizjuan 4, 41009, Seville, Spain.
Amalia Rubio
Isabel Cerrillo
Araceli Gómez-Corvera
Antonio Carrillo-Vico
Marina Sanchez-Hidalgo
Juan M Guerrero
Patricia Fernandez-Riejos
Victor Sanchez-Margalet
Patrocinio Molinero
Hospital Universitario Virgen Macarena · ESInstituto de Biomedicina de Sevilla · ESUniversidad de Sevilla · ESConsejo Superior de Investigaciones Científicas · ESHospital Universitario Virgen del Rocío · ESUniversidad Pablo de Olavide · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melatonin has been proposed as regulating the immune system by affecting cytokine production in immunocompetent cells, enhancing the production of several T helper (Th)1 cytokines. To further investigate the melatonin's role in IL-2/IL-2R system, we established an inducible T-REx expression system in Jurkat cells in which the protein levels of HIOMT enzyme or MT(1) receptor were significantly down-regulated upon tetracycline incubation. We found that T-REx Jurkat cells with lower levels of HIOMT activity, and consequently lower content of endogenous melatonin, showed IL-2 production decrease after activation with lectin. Likewise, tetracycline-inducible stable cell line expressing MT(1) antisense produced decreased amounts of IL-2 (mRNA and protein levels) after stimulation. Moreover, in T-Rex-MT(1) cells incubated with tetracycline, a sub-optimal PHA dose failed to induce the early activation marker CD25 on the cell surface. The results shown here support the relevance of endogenous melatonin and its signaling in T cell activation.

Indexed as

Lymphocyte ActivationAcetylserotonin O-MethyltransferaseHumansInterleukin-2Jurkat CellsMelatoninReceptor, Melatonin, MT1Signal TransductionT-LymphocytesAcetylserotonin O-MethyltransferaseInterleukin-2MelatoninReceptor, Melatonin, MT1

Identifiers

PMID20440532
PMCPMC11115585
OpenAlexW2061956950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.